| Phase 2/3 |
| NCT05371613 |
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase… |
Mucopolysaccharidosis II |
Active, Not Recruiting |
2026-09-09 |
| NCT06075537 |
An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp… |
Mucopolysaccharidosis II |
Enrolling by Invitation |
2026-06-11 |
| Phase 2 |
| NCT06602193 |
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated… |
Parkinson Disease |
Active, Not Recruiting |
2026-05-27 |
| Phase 1/2 |
| NCT06181136 |
Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA… |
Mucopolysaccharidosis Type IIIA |
Active, Not Recruiting |
2026-07-13 |
| NCT05262023 |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… |
Frontotemporal Dementia |
Active, Not Recruiting |
2026-01-15 |
| NCT04251026 |
A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome |
Mucopolysaccharidosis II |
Active, Not Recruiting |
2025-08-07 |
| Phase 1 |
| NCT07758595 |
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in… |
Alzheimer's Disease |
Recruiting |
2026-08-20 |
| NCT07354724 |
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult… |
Late-onset Pompe Disease |
Recruiting |
2026-08-17 |
| NCT07328451 |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… |
Alzheimer Disease, Early Onset |
Recruiting |
2026-07-01 |